Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Beta-blockers do not benefit heart attack patients with a normal LVEF
The new meta-analysis included data from nearly 18,000 patients. Overall, patient outcomes were quite similar for patients who did and did not undergo beta-blocker therapy.
Oral heart failure drug receives FDA’s fast track designation
A clinical trial focused on patients with HFpEF is expected to be completed by July 2026.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring
According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.
Drones deliver AEDs for the first time in the United States
“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."

Where COVID-19 is hitting state economies the hardest

Louisiana is the most exposed state economy when it comes to the new coronavirus, COVID-19.

FDA approves new solution for reducing heart muscle damage after serious heart attacks

ZOLL Medical Corporation has gained FDA approval for its new SuperSaturated Oxygen (SSO2) therapy solution for treating heart muscle damage in “widowmaker” heart attacks patients.

CMS eases regulations for COVID-19 response

CMS is allowing healthcare providers to react to the COVID-19 pandemic with greater flexibility by loosening some federal requirements and issuing sweeping new rules.

Hypertension and COVID-19: 4 key things patients should know

What, exactly, do patients need to know about the relationship between hypertension and COVID-19?

TAVR outcomes worse than expected at 11% of US facilities

Transcatheter aortic valve replacement (TAVR) outcomes have been worse than expected for 11% of healthcare providers in the United States, according to a new analysis of data from 2015 to 2017.

HHS accelerates clinical trials for COVID-19 vaccines

HHS is speeding up the development and manufacturing of COVID-19 vaccines by partnering with Johnson & Johnson-owned Janssen Research and Development and Moderna Therapeutics.

EuroHeartCare 2020 canceled over COVID-19 concerns

The event was scheduled to occur June 4-6 in Seville, Spain. It has been rescheduled for June 17-19, 2021.

For TAVR patients with AFib, antiplatelet medication linked to poorer outcomes

Oral anticoagulation medication can help minimize bleeding complications among AFib patients undergoing transcatheter aortic valve replacement (TAVR), according to new research out of Europe.

Clinical

Beta-blockers do not benefit heart attack patients with a normal LVEF

Oral heart failure drug receives FDA’s fast track designation

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring

Drones deliver AEDs for the first time in the United States